New Questions Raised About Tamiflu’s Effectiveness
01/18/2012 - By Andrew Pollack
(Excerpt from article)
"A new review of medical evidence continues to raise questions about the safety and effectiveness of the influenza drug Tamiflu, which the United States and other nations have spent billions of dollars to stockpile for use in a possible flupandemic.
The review concluded that Tamiflu could reduce the duration of flu symptoms by about 21 hours, from the typical six or seven days. But the reviewers said they could not confirm two other purported effects of the drug often cited as reasons for using it in a pandemic – that it reduced complications of flu, likepneumonia or hospitalizations, and that it reduced transmission of the virus."